29 October 2020
Visiongain has published a new report on Cleanroom Technology Market Report : Forecasts by Product (HVAC, HEPA Filters, Apparel, Vacuum Systems, Gloves, Disinfectants), by Construction (Drywall, Hardwall, Softwall), by End-User (Pharmaceutical, Biotechnology, Hospitals). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Global Cleanroom technology market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031.
Technological advancement in cleanroom equipment for expanding this sector private and public organisations are taking huge initiatives for awareness in this sector.
Manufacturing companies in various sector are becoming dependent on cleanroom technology to fulfil strict norms regulations. Moreover there has been an increase in need for standardising cleanroom standards due to presence of a wide range of classifications used by different countries such as US., UK, and Germany which is further bolstering the growth.
The regulations are stricter towards pharmaceutical and medical devices instruments industries as compared to the other industries because these two sector connects with the public health.Moreover, various efforts such as directories is magazine and papers gives a boost to this market.
According to the report of Centres for Disease Control and Prevention (CDC), there were about 722000 Hospital Acquired Infections (HAI) in US. As up to 2018. According to the data published by National institute for health and care excellence, in England nearly 300000 patients in a year acquire HAI as a result of care within the National Health Service. Hence the need of cleanroom sector will grow in future. Thus these factors boost the growth of the market.
COVID impact on Cleanroom technology market
According to the analysis, some factors are playing key role for growth of mentioned market.
-Due to COVID-19 pandemic, questions are raising for health security of people. Pharmaceutical companies are under pressure for complains of rules and regulations for the efficiency and purity of certain high cost drug.
-in this end of a decade healthcare industries are facing huge problems of supplying certain healthcare products such as personal protective equipment’s (PPE) ventilators and other highly important medicines.
- Hospital are running short of theircapacity due to increase in patients which is highly dependent on pharmaceutical industries.
Cleanroom technology market drivers
Strict regulations- with the increase in certified medical products, various national institution have been given guidelines to the medical industries for compiling various strict regulations for the good quality of the product. They have been given instruction to go under cleanroom for better efficiency of the product.
Increase in demand of cleanrooms- due to increase in pharmaceutical and medical health industries, and these industries have compulsion to undergo the process of cleanroom, so cleanroom industries will be boosted in few years
The focus on enhanced safety and quality of healthcare products, hygiene and safety of working personnel, along withenvironmental concerns propels the usage of cleanroom in healthcare industry.
Increasing demand for sterilizedpharmaceutical formulations coupled with advancements in medical devices is expected to drive the demand for cleanrooms
The cleanroom technology market on the source of type of end user could span hospitals and diagnostic centres, medical device manufacturing, biotechnology industry, pharmaceutical industry. The subdivision of biotechnology detained the subsequent biggest stake of income.
Some of the companies profiled in the report include Azbil Corporation (Japan), Kimberly-Clark Corporation (US), Ardmac (Ireland), Clean Air Products (US), Labconco Corporation (US), Dynarex Corporation (US), DowDuPont Inc. (US), Illinois Tool Works Inc. (US), Taikisha Ltd. (Japan), Exyte AG (Germany), COLANDIS GmbH (Germany), ABN Cleanroom Technology (Belgium), Clean Rooms International, Inc. (US), Bouygues Group (France), Terra Universal, Inc. (US), Connect 2 Cleanrooms Ltd (UK), Camfil (Sweden), OCTANORM-Vertriebs-GmbH (Germany), Parteco Srl (Italy), and Airtech Japan, Ltd. (Japan)
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.
26 November 2020
Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.
26 November 2020
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.
25 November 2020
Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth